Active compounds of licorice ameliorate microplastics-induced intestinal damage by targeting FADD
Wen Xue1, Xiuhe Fan1, Yujing Hui1
1Co-construction Collaborative Innovation Center for Chinese Medicine Resources Industrialization by Shaanxi & Education Ministry/State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation)/Shaanxi Innovative Drug Research Center, Shaanxi University of Chinese Medicine, Xianyang, 712046, China.
Abstract:
Microplastics (MPs), as a novel type of environmental pollutant, have the potential to impact human health. This study aims to investigate the protective efficacy of active compounds in licorice on microplastics-injured rats and reveal the underlying mechanisms. The MPs-injured rat model was established by orally administrated with MPs. After the treatment with different doses of a combination of liquiritigenin, isoliquiritigenin and glycyrrhetinic acid, the tissue injury, oxidative stress, inflammation and expressions of tight junction proteins in colon and liver were evaluated. Our data showed that active compounds of licorice significantly ameliorate colonic and liver damage caused by MPs, improving function colonic barrier and liver function, reducing oxidative stress and systemic inflammatory factors. Then, a total of 29 differentially expressed proteins were identified by label-free proteomics analysis, among which the down-regulated Fas-associating protein with a novel death domain (FADD) was found to be the most related with the protective effects of licorice. What's more, this protein target also interacts directly with active compounds of licorice, through hydrogen bounds and hydrophobic interactions involving 11 residues. This study suggested that licorice exerts protective effects against MPs on rats, through down-regulating as well as directly interacting with FADD.
Insights
Licorice compounds protect rats from microplastic (MP) injury by reducing inflammation and improving organ function. These effects are linked to down-regulating and interacting with the FADD protein.
Area of Science:
- Environmental Science
- Toxicology
- Pharmacology
Background:
- Microplastics (MPs) are emerging environmental pollutants with potential human health risks.
- The impact of MPs on internal organs like the colon and liver requires further investigation.
- Licorice and its active compounds possess known anti-inflammatory and antioxidant properties.
Purpose of the Study:
- To evaluate the protective effects of licorice active compounds against MP-induced injury in rats.
- To elucidate the underlying molecular mechanisms of licorice's protective action.
- To identify specific protein targets involved in the therapeutic response.
Main Methods:
- Establishment of a rat model with microplastic-induced colon and liver injury.
- Treatment with a combination of liquiritigenin, isoliquiritigenin, and glycyrrhetinic acid.
- Assessment of tissue damage, oxidative stress, inflammation, and tight junction proteins.
- Label-free proteomics to identify differentially expressed proteins.
Main Results:
- Licorice compounds significantly ameliorated colonic and liver damage induced by MPs.
- Improved colonic barrier function and liver function were observed.
- Reduced oxidative stress and systemic inflammatory factors were noted.
- Fas-associating protein with a novel death domain (FADD) was identified as a key down-regulated protein interacting with licorice compounds.
Conclusions:
- Licorice active compounds demonstrate significant protective efficacy against microplastic-induced tissue injury in rats.
- The protective mechanism involves down-regulating FADD and direct interaction with the protein.
- This study highlights licorice as a potential therapeutic agent for microplastic-related health issues.
More Related Videos
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
